John H. Sloan
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Chronic Obstructive Pulmonary Disease (COPD) Research, Iron Metabolism and Disorders, Erythropoietin and Anemia Treatment, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL(2017)634 cited
- → Handgun Regulations, Crime, Assaults, and Homicide(1988)234 cited
- → Firearm Regulations and Rates of Suicide(1990)220 cited
- → Objective Documentation of Traumatic Brain Injury Subsequent to Mild Head Trauma(2007)219 cited
- → The Novel Apolipoprotein A5 Is Present in Human Serum, Is Associated with VLDL, HDL, and Chylomicrons, and Circulates at Very Low Concentrations Compared with Other Apolipoproteins(2004)213 cited
- → Quantitative proton MRS predicts outcome after traumatic brain injury(1999)185 cited
- → The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes(2014)170 cited
- → Brain reward‐system activation in response to anticipation and consumption of palatable food is altered by glucagon‐like peptide‐1 receptor activation in humans(2015)135 cited
- Neuromagnetic assessment of pathophysiologic brain activity induced by minor head trauma.(1999)
- → High-dose vitamin D 3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults(2016)107 cited